Hugo Nodarse-Cuní

Statistics

Publications

Citations

H-Index

Active since

2004

Affiliations

Centro de Ingeniería Genética y Biotecnología(Current)

Hugo Nodarse-Cuní is an author at Centro de Ingeniería Genética y Biotecnología specializing in interferon alfa therapy, interferon-based therapy, and interferon alpha-2b therapy.

ORCID

Publications per year

2004–2020

Publications

Pharmacokinetic and pharmacodynamic comparison of two "pegylated" interferon alpha-2 formulations in healthy male volunteers: a randomized, crossover, double-blind study

Idrian García‐García, Carlos Alberto González-Delgado, Carmen Valenzuela‐Silva et al. · BMC Pharmacology · 2010 · 32 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +13

Interferon alpha-2b as adjuvant treatment of recurrent respiratory papillomatosis in Cuba: National Programme (1994–1999 report)

Hugo Nodarse-Cuní, Nora Iznaga-Marín, Ditza Viera Álvarez et al. · The Journal of Laryngology & Otology · 2004 · 29 citations

Pharmacy, Pharmacotherapy, Surgery +13

Effect of combination of interferon alpha-2b and interferon-gamma or interferon alpha-2b alone for elimination of SARS-CoV-2 viral RNA. Preliminary results of a randomized controlled clinical trial

Esquivel-Moynelo I Idelsis, Jesus Perez-Escribano, Yaquelín Duncan-Roberts et al. · medRxiv · 2020 · 24 citations

Veterinary Medicine, Immunology, Infectious Diseases +17

Cuban interferon alpha-2b. Thirty years as an effective and safe drug

Hugo Nodarse-Cuní, Pedro López‐Saura · DOAJ (DOAJ: Directory of Open Access Journals) · 2017 · 13 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +5

1–4 of 4